Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Mast launches new CPE detection test

Mast launches new CPE detection test

19th June 2017

Mast has announced the launch of a simple new test to aid the detection of carbapenemase-producing Enterobacteriaceae (CPE).

The Mastdiscs Combi Carba Plus assay has been developed for the phenotypic confirmation of carbapenemase activity amongst Enterobacteriaceae, with its five-disc system enabling the differentiation of MBL, KPC and OXA-48-like carbapenemases.

Capabilities include reliable discrimination of KPC from AmpC-producing isolates, while the addition of a temocillin disc containing an MBL inhibitor – rather than a temocillin-only disc –  prevents MBLs from being incorrectly identified as OXA-48.

This is important because CPE detection is typically considered difficult due to the diverse range of resistance profiles employed among differing carbapenemase enzymes.

The manufacturer said: "Although there are a variety of tests available for the detection of MBL and KPC enzymes, OXA-48-like enzymes continue to be problematic in their identification."

Mast believes this new product offering will be a useful tool in the fight against antibiotic resistance, particularly as the incidence of CPE rises and limits the effectiveness of current antibiotics.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801836983-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.